This special episode includes presentations from a recent workshop, where Dr. Alaina Jaster, Dr. Neşe Devenot of Johns Hopkins and Dr. Gill Bedi of University of Melbourne presented their expertise and perspectives on how the psychedelic research field can move forward from the recent FDA rejection of MDMA-AT.

Dr. Jaster's presentation sets the tone by going over recent events, followed by how researchers can be involved in promoting evidence-based regulatory and policy decisions.

Dr. Devenot's presentation focused on what it means to be a psychedelic bioethicist and how the recent events have conflated constructive criticism with attacks, followed by a call to be better about having these discussions.

Dr. Bedi's presentation discussed how scientists studying MDMA and other psychedelics can better their study design and use methodology that is evidence-based and thorough.

These taken together, provided the framework for how to move forward in the field and prompted a discussion by members in the crowd (of which was not recorded to protect those participating).

For more information and to see some of the slides, you can go to psychedeliccbrainscience.com